Universitätsklinikum Heidelberg

Ärztlicher / Beruflicher Werdegang

seit 2026

Head, Divison of Gynecologic Pathology, Institute of Pathology, University Hospital Heidelberg, Germany

seit 2026

Senior Consultant in Surgical Pathology, Institute of Pathology, University Hospital Heidelberg, Germany

seit 2025

Consultant in Surgical Pathology, Institute of Pathology, University Hospital Heidelberg, Germany

seit 2025

Board Certification in Surgical Pathology

2018 – 2025

Clinical Residency, Institute of Pathology, University Hospital Heidelberg, Germany

seit 2018

MD thesis (Dr. med., summa cum laude), University of Tübingen, Germany 

seit Dezember 2017

License to Practice medicine 

2012 – 2014

Business Economist (IWW), Institut für WiWi Forschung und Weiterbildung, Fernuniversität-Hagen, Germany 

2011 – 2017

Medical School, University of Freiburg, Germany 

Wissenschaftlicher Werdegang

2023 – 2024

Postdoctoral Fellow, Department of Pathology and Laboratory Medicine, University of British Columbia (UBC) and BC Cancer Agency, Vancouver, Canada (Dr. David Huntsman & Dr. Blake Gilks) 

Auszeichnungen

2025

Virchows Archiv Best Paper Award for Young Investigators, European Society of Pathology (ESP) 

2024

Young Member Award, International Society for Gynecologic Pathology (ISGyP) 

2024

Walter Benjamin Fellowship, Deutsche Forschungsgemeinschaft (DFG) 

2022

Poster Award, International Society for Gynecologic Pathology (ISGyP), USCAP Annual Meeting Los Angeles, USA 

2019

Dissertation Award, University of Tübingen, Germany 

2020 – 2022

Physician Scientist Fellowship, Medical Faculty of the University of Heidelberg, Germany 

2018

Poster awards, Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e.V., 

DGGG Kongresse Berlin und München

2014

Poster awards, Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e.V., 

DGGG Kongresse Berlin und München

Selected Publications

Sowamber R, Mei AJ, Kaur P, McLeod J, McKay E, Lukey A, Bakkum-Gamez J, Buza N, Cohen PA, Devins K, Farrell R, Garcia C, Gilks B, Goode E, Hodgson A, Howitt B, Hui P, Huvila J, Karnezis A, Keyhanian K, Kinloch M, Köbel M, Kommoss FK, Kushi L, Kwon JS, Long-Roche K, Malpica A, McAlpine JN, Miller D, Oliva E, Palicelli A, Paliga A, Parra-Herran C, Pearce CL, Perera S, Piek JM, Qiu H, Rabban J, Rome R, Steenbeek M, Stone R, Talhouk A, Tischer KM, Trabert B, Webb PM, Zalcberg JR, Huntsman DG, Hanley GE. Serous Ovarian Cancer Following Opportunistic Bilateral Salpingectomy. JAMA Netw Open. 2026 Feb 2;9(2):e2557267.

Lee CH, Lee YS, Bennett JA, Kolin DL, Lee JC, Huang HY, Köbel M, Sementsov M, Dickson BC, Koelsche C, Kommoss F, von Deimling A, Kommoss FK. GREB1-rearranged uterine tumour shares a common DNA methylation signature with ESR1-rearranged UTROSCT. Histopathology. 2025 Dec 22.

Ngeow J, Chiang J, Astiazaran-Symonds E, Balmaña J, Cass I, Kommoss FK, Foulkes WD, James PA, Katcher A, Klugman S, Livinski AA, Mak JS, Voian N, Wick MJ, Tischkowitz M, Pal T, Stewart DR, Hanson H; ACMG Professional Practice and Guidelines Committee. Electronic address: documents@acmg.net. Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2025 Nov;27(11):101557.

Kommoss FK, Chong AS, Chong AL, Pfaff E, Jones DTW, Hiemcke-Jiwa LS, Kester LA, Flucke U, Gessler M, Schrimpf D, Sahm F, Clarke BA, Stewart CJR, Wang Y, Gilks CB, Kommoss F, Huntsman DG, Schüller U, Koelsche C, McCluggage WG, von Deimling A, Foulkes WD. Genomic characterization of DICER1-associated neoplasms uncovers molecular classes. Nat Commun. 2023 Mar 25;14(1):1677.

Kommoss FK, Mar LM, Howitt BE, Hanley K, Turashvilli G, Buslei R, Irving JA, Dickson BC, Koelsche C, Sinn HP, Schirmacher P, von Deimling A, Chiang S, McCluggage WG, Croce S, Stewart CJR, Lee CH. High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker. Mod Pathol. 2023 Mar;36(3):100044.

Bolkestein M, Wong JKL, Thewes V, Körber V, Hlevnjak M, Elgaafary S, Schulze M, Kommoss FK, Sinn HP, Anzeneder T, Hirsch S, Devens F, Schröter P, Höfer T, Schneeweiss A, Lichter P, Zapatka M, Ernst A. Chromothripsis in Human Breast Cancer. Cancer Res. 2020 Nov 15;80(22):4918-4931.

Kommoss FK, Chang KT, Stichel D, Banito A, Jones DT, Heilig CE, Fröhling S, Sahm F, Stenzinger A, Hartmann W, Mechtersheimer G, Sinn HP, Schmidt D, Kommoss F, von Deimling A, Koelsche C. Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications. J Pathol Clin Res. 2020 Jul;6(3):178-184.

Kommoss FK, Karnezis AN, Kommoss F, Talhouk A, Taran FA, Staebler A, Gilks CB, Huntsman DG, Krämer B, Brucker SY, McAlpine JN, Kommoss S. L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile. Br J Cancer. 2018 Aug;119(4):480-486.